These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21158667)

  • 1. Dosing of clopidogrel and aspirin in acute coronary syndromes.
    Padrini R; Pengo V
    N Engl J Med; 2010 Dec; 363(25):2465-6; author reply 2467-8. PubMed ID: 21158667
    [No Abstract]   [Full Text] [Related]  

  • 2. Dosing of clopidogrel and aspirin in acute coronary syndromes.
    Merella P; Casu G; Meloni I
    N Engl J Med; 2010 Dec; 363(25):2466-7; author reply 2467-8. PubMed ID: 21158665
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.
    ; Mehta SR; Bassand JP; Chrolavicius S; Diaz R; Eikelboom JW; Fox KA; Granger CB; Jolly S; Joyner CD; Rupprecht HJ; Widimsky P; Afzal R; Pogue J; Yusuf S
    N Engl J Med; 2010 Sep; 363(10):930-42. PubMed ID: 20818903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosing of clopidogrel and aspirin in acute coronary syndromes.
    Vassiliou VS
    N Engl J Med; 2010 Dec; 363(25):2466; author reply 2467-8. PubMed ID: 21158666
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute coronary syndromes: finding meaning in OASIS 7.
    Stone GW
    Lancet; 2010 Oct; 376(9748):1203-5. PubMed ID: 20817280
    [No Abstract]   [Full Text] [Related]  

  • 6. Double-dose clopidogrel in patients undergoing PCI for ACS.
    Schiele F
    Lancet; 2011 Jan; 377(9762):297; author reply 298. PubMed ID: 21256376
    [No Abstract]   [Full Text] [Related]  

  • 7. Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy.
    Mehta SR; Bassand JP; Chrolavicius S; Diaz R; Fox KA; Granger CB; Jolly S; Rupprecht HJ; Widimsky P; Yusuf S;
    Am Heart J; 2008 Dec; 156(6):1080-1088.e1. PubMed ID: 19033002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-dose clopidogrel in patients undergoing PCI for ACS.
    Vassiliou V
    Lancet; 2011 Jan; 377(9762):297; author reply 298. PubMed ID: 21256377
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to antiplatelet treatment: from genes to outcome.
    Giusti B; Abbate R
    Lancet; 2010 Oct; 376(9749):1278-81. PubMed ID: 20801497
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiplatelet resistance--fact or myth?
    Gurbel PA; Tantry US
    Am Heart Hosp J; 2009; 7(1):50-7. PubMed ID: 19742434
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiplatelet therapy in acute coronary syndrome: not as confusing as you think.
    Thomas J; Brady WJ
    J Emerg Med; 2008 Jul; 35(1):87-90. PubMed ID: 18325715
    [No Abstract]   [Full Text] [Related]  

  • 12. Exploring PLATO-USA paradox and CURRENT-OASIS 7 trials reveals the benefit of higher aspirin dose.
    DiNicolantonio JJ; Serebruany VL
    Am J Ther; 2015; 22(1):85-6. PubMed ID: 23728159
    [No Abstract]   [Full Text] [Related]  

  • 13. Ad hoc percutaneous coronary intervention after in-laboratory high dose clopidogrel loading for clopidogrel-naive patients: safe for all?
    Davlouros P; Alexopoulos D
    Am J Cardiol; 2010 Jul; 106(1):139-40; author reply 140-1. PubMed ID: 20609662
    [No Abstract]   [Full Text] [Related]  

  • 14. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.
    Mehta SR; Tanguay JF; Eikelboom JW; Jolly SS; Joyner CD; Granger CB; Faxon DP; Rupprecht HJ; Budaj A; Avezum A; Widimsky P; Steg PG; Bassand JP; Montalescot G; Macaya C; Di Pasquale G; Niemela K; Ajani AE; White HD; Chrolavicius S; Gao P; Fox KA; Yusuf S;
    Lancet; 2010 Oct; 376(9748):1233-43. PubMed ID: 20817281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evidences about combination use of acetylsalicylic acid (aspirin) and clopidogrel in acute coronary syndrome].
    Velázquez de Campos O
    Invest Clin; 2017 Mar; 58(1):79-91. PubMed ID: 29939512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin combined with clopidogrel (Plavix) decreases cardiovascular events in patients with acute coronary syndrome.
    Walker CW; Dawley CA; Fletcher SF
    Am Fam Physician; 2007 Dec; 76(11):1643-5. PubMed ID: 18092705
    [No Abstract]   [Full Text] [Related]  

  • 17. The loading dose of clopidogrel in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty.
    Lin GM; Han CL
    Am J Emerg Med; 2010 Mar; 28(3):382-3. PubMed ID: 20223400
    [No Abstract]   [Full Text] [Related]  

  • 18. Fine-tuning therapy for acute coronary syndromes.
    Fuster V
    N Engl J Med; 2010 Sep; 363(10):976-7. PubMed ID: 20818910
    [No Abstract]   [Full Text] [Related]  

  • 19. [The CURRENT-OASIS 7 study].
    Ardissino D; Patti G; Magnani G; Mantovani F; Demola MA
    G Ital Cardiol (Rome); 2011 Mar; 12(3):167-71. PubMed ID: 21560471
    [No Abstract]   [Full Text] [Related]  

  • 20. Adverse events associated with stopping clopidogrel after acute coronary syndrome.
    Goyal SK; Punnam SR
    JAMA; 2008 May; 299(20):2389; author reply 2389-90. PubMed ID: 18505946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.